FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kirk Frey

Research Profile

Anatomy

Procedures

Chemicals & Drugs

Living Beings

Rats

Disorders

Concepts & Ideas

Tissue Distribution

Co-author Network

Publications

TOP 3
Vikas Kotagal; Martijn L T M Müller; Roger L Albin; Kirk A Frey; Robert A Koeppe; Nicolaas I Bohnen
Diabetes is associated with postural instability and gait difficulty in Parkinson disease.
Anca M Avram; Lorraine M Fig; Kirk A Frey; Milton D Gross; Ka Kit Wong
Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging?
Martijn L T M Müller; Myria Petrou; Roger L Albin; Kirk A Frey; Robert A Koeppe; Vikas Kotagal; Nicolaas I Bohnen
β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kirk Frey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vikas Kotagal; Martijn L T M Müller; Roger L Albin; Kirk A Frey; Robert A Koeppe; Nicolaas I Bohnen
Diabetes is associated with postural instability and gait difficulty in Parkinson disease.
Parkinsonism & related disorders 2013;19(5):522-6.
2013: Anca M Avram; Lorraine M Fig; Kirk A Frey; Milton D Gross; Ka Kit Wong
Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging?
The Journal of clinical endocrinology and metabolism 2013;98(3):1163-71.
2013: Martijn L T M Müller; Myria Petrou; Roger L Albin; Kirk A Frey; Robert A Koeppe; Vikas Kotagal; Nicolaas I Bohnen
β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia.
Movement disorders : official journal of the Movement Disorder Society 2013;28(3):296-301.
2012: Vikas Kotagal; Martijn L T M Müller; Nicolaas I Bohnen; Kirk A Frey; Robert A Koeppe; Roger L Albin
Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease.
Archives of neurology 2012;69(12):1628-31.
2012: Ka Kit Wong; Nicolaas I Bohnen; Kirk A Frey; Robert A Koeppe; David M Raffel; Sid Gilman
Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET.
Radiology 2012;265(1):240-7.
2012: Myria Petrou; Roger L Albin; Nicolaas I Bohnen; Robert A Koeppe; Martijn L T M Müller; Kirk A Frey
Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.
Neurology 2012;79(11):1161-7.
2012: Dominique Delbeke; Kirk A Frey; Michael M Graham; Henry D Royal; George M Segall
SNMMI/ABNM joint position statement on optimizing training in nuclear medicine in the era of hybrid imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(9):1490-4.
2012: Kevin J Donohoe; Kirk A Frey; Victor H Gerbaudo; Giuliano Mariani; James S Nagel; Barry L Shulkin; Michael G Stabin; Garima Agrawal; Margaret K Stokes
SNM practice guideline for brain death scintigraphy 2.0.
Journal of nuclear medicine technology 2012;40(3):198-203.
2012: Nicolaas I Bohnen; Roger L Albin; Sid Gilman; Michael R Kilbourn; Robert A Koeppe; Vikas Kotagal; Martijn L T M Müller; Kirk A Frey
Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2012;32(8):1609-17.
2012: Vikas Kotagal; Martijn L T M Müller; Roger L Albin; Ronald D Chervin; Kirk A Frey; Robert A Koeppe; Nicolaas I Bohnen
Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.
Annals of neurology 2012;71(4):560-8.
2012: Shuanghu Tiger Yuan; Jean M Moran; Nithya Ramnath; Randall K Ten Haken; Douglas Arenberg; Xu-Wei Cai; Avraham Eisbruch; Kirk A Frey; Milton D Gross; Khaled Hassan; James A Hayman; Fengming P Kong
Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2012;82(4):e631-8.
2012: Irene M Lelieveld; Martijn L T M Müller; Nicolaas I Bohnen; Ronald D Chervin; Kirk A Frey; Robert A Koeppe; Roger L Albin
The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study.
PloS one 2012;7(7):e40166.
2012: Tal Shafir; Heng Wang; Jon K Zubieta; Alison Berent-Spillson; Kirk A Frey; Tiffany Love; Carol Persad; Nancy K Reame; Yolanda R Smith
Postmenopausal hormone use impact on emotion processing circuitry.
Behavioural brain research 2012;226(1):147-53.
2011: Yolanda R Smith; Alison Berent-Spillson; Luvina Bowen; Kirk A Frey; Robert A Koeppe; Tiffany M Love; Carol Persad; Nancy K Reame; Jon K Zubieta
Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity.
The Journal of clinical endocrinology and metabolism 2011;96(11):E1761-70.
2011: Nicolaas I Bohnen; Kirk A Frey; Michael R Kilbourn; Robert A Koeppe; Martijn L T M Müller; Natalia Zarzhevsky; Christopher W Bogan; Roger L Albin
Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.
Brain : a journal of neurology 2011;134(Pt 8):2358-65.
2011: Dustin Hammers; Judith L Heidebrink; Carol Persad; Kelly Ryan; Elizabeth Spurgeon; Roger L Albin; Nancy R Barbas; David Darby; Kirk A Frey; Bruno Giordani
Reliability of repeated cognitive assessment of dementia using a brief computerized battery.
American journal of Alzheimer's disease and other dementias 2011;26(4):326-33.
2011: Kirk A Frey; Henry D Royal; Marcelo F Di Carli; Gary L Dillehay; Leonie Gordon; David A Mankoff; Janis O'Malley; Lalitha Ramanna; Eric Rohren; George M Segall; Barry L Shulkin; Jerold W Wallis; Harvey A Ziessman
ABNM position statement: Nuclear medicine professional competency and scope of practice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(6):994-7.
2011: Nicolaas I Bohnen; Robert A Koeppe; Satoshi Minoshima; Bruno Giordani; Roger L Albin; Kirk A Frey; David E Kuhl
Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(6):848-55.
2011: James F Burke; Roger L Albin; Robert A Koeppe; Bruno Giordani; Michael R Kilbourn; Sid Gilman; Kirk A Frey
Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography.
Brain : a journal of neurology 2011;134(Pt 6):1647-57.
2011: Ka Kit Wong; Elizabeth A Wynn; Jamie Myles; Robert J Ackermann; Kirk A Frey; Anca M Avram
Comparison of single time-point [111-In] pentetreotide SPECT/CT with dual time-point imaging of neuroendocrine tumors.
Clinical nuclear medicine 2011;36(1):25-31.
2011: Shuanghu Tiger Yuan; Kirk A Frey; Milton D Gross; James A Hayman; Douglas Arenberg; Jeffrey L Curtis; Xu-Wei Cai; Nithya Ramnath; Gregory P Kalemkerian; Randall K Ten Haken; Avraham Eisbruch; Fengming P Kong
Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potential indication for radiotherapy planning.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(1):71-8.
2010: Ka Kit Wong; James C Sisson; Kenneth F Koral; Kirk A Frey; Anca M Avram
Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
AJR. American journal of roentgenology 2010;195(3):730-6.
2010: R Kochhar; Richard K J Brown; C O Wong; N Reed Dunnick; Kirk A Frey; P Manoharan
Role of FDG PET/CT in imaging of renal lesions.
Journal of medical imaging and radiation oncology 2010;54(4):347-57.
2010: Alison Berent-Spillson; Carol Persad; Tiffany Love; Anne Tkaczyk; Heng Wang; Nancy K Reame; Kirk A Frey; Jon K Zubieta; Yolanda R Smith
Early menopausal hormone use influences brain regions used for visual working memory.
Menopause (New York, N.Y.) 2010;17(4):692-9.
2010: Neil Hansen; Richard K J Brown; Asra Khan; Kirk A Frey; Mark B Orringer
False positive diagnosis of metastatic esophageal carcinoma on positron emission tomography: a case report of cholecystitis simulating a hepatic lesion.
Clinical nuclear medicine 2010;35(6):409-12.
2010: Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael R Kilbourn; Roger L Albin; Kirk A Frey
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.
Brain : a journal of neurology 2010;133(Pt 6):1747-54.
2010: Cherine Fahim; Uicheul Yoon; Samir Das; Oliver Lyttelton; John Chen; Rozie Arnaoutelis; Guy Rouleau; Paul Sandor; Kirk A Frey; Catherine Brandner; Alan C Evans
Somatosensory-motor bodily representation cortical thinning in Tourette: effects of tic severity, age and gender.
Cortex; a journal devoted to the study of the nervous system and behavior 2010;46(6):750-60.
2010: Roger L Albin; Robert A Koeppe; James F Burke; Bruno Giordani; Michael R Kilbourn; Sid Gilman; Kirk A Frey
Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
Archives of neurology 2010;67(4):440-6.
2010: Ka Kit Wong; John M Cahill; Kirk A Frey; Anca M Avram
Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors.
Academic radiology 2010;17(3):291-7.
2010: Rajen J Mody; Chuong Bui; Raymond J Hutchinson; Gregory Yanik; Valerie P Castle; Kirk A Frey; Barry L Shulkin
FDG PET imaging of childhood sarcomas.
Pediatric blood & cancer 2010;54(2):222-7.
2010: Michael R Kilbourn; Elizabeth R Butch; Timothy Desmond; Phillip Sherman; Paul E Harris; Kirk A Frey
In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations.
Nuclear medicine and biology 2010;37(1):3-8.
2009: Nicolaas I Bohnen; M L T M Müller; Robert A Koeppe; S A Studenski; Michael R Kilbourn; Kirk A Frey; Roger L Albin
History of falls in Parkinson disease is associated with reduced cholinergic activity.
Neurology 2009;73(20):1670-6.
2009: Jonathan R Dillman; Ka Kit Wong; Richard K J Brown; Kirk A Frey; Peter J Strouse
Utility of SPECT/CT with Meckel's scintigraphy.
Annals of nuclear medicine 2009;23(9):813-5.
2009: Cherine Fahim; Uicheul Yoon; Paul Sandor; Kirk A Frey; Alan C Evans
Thinning of the motor-cingulate-insular cortices in siblings concordant for Tourette syndrome.
Brain topography 2009;22(3):176-84.
2009: Ka Kit Wong; N Zarzhevsky; J M Cahill; Kirk A Frey; Anca M Avram
Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma.
The British journal of radiology 2009;82(982):860-76.
2009: Matthew Scott Davenport; Richard K J Brown; Kirk A Frey
Utility of delayed whole-body bone scintigraphy after directed three-phase scintigraphy.
AJR. American journal of roentgenology 2009;193(2):338-42.
2009: Michael R Kilbourn; Brian Hockley; Lihsueh Lee; Phillip Sherman; Carole Quesada; Kirk A Frey; Robert A Koeppe
Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter.
Nuclear medicine and biology 2009;36(5):489-93.
2009: Roger L Albin; Robert A Koeppe; Kris Wernette; W Zhuang; T Nichols; Michael R Kilbourn; Kirk A Frey
Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome.
Neurology 2009;72(16):1390-6.
2009: Douglas B Chepeha; Assuntina G Sacco; Lance E Oxford; Rahul Karamchandani; Tamara H Miller; Theodoros N Teknos; Carol R Bradford; Avraham Eisbruch; Frank M Worden; Susan G Urba; Suresh K Mukherji; Chuong Bui; Kirk A Frey; Gregory T Wolf; Julia S Lee
Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy.
Head & neck 2009;31(4):452-60.
2009: A C Ludolph; J Kassubek; B G Landwehrmeyer; Eva-Maria Mandelkow; Eckhard Mandelkow; David J Burn; D Caparros-Lefebvre; Kirk A Frey; J G de Yebenes; T Gasser; Peter Heutink; G Höglinger; Z Jamrozik; Kurt A Jellinger; A Kazantsev; Hans A Kretzschmar; Anthony E Lang; I Litvan; J J Lucas; Patrick L McGeer; S Melquist; Wolfgang H Oertel; M Otto; D Paviour; T Reum; A Saint-Raymond; J C Steele; M Tolnay; H Tumani; J C van Swieten; M T Vanier; J-P Vonsattel; S Wagner; Zbigniew K Wszolek
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(3):297-309.
2008: Ka Kit Wong; Natalia Zarzhevsky; John Cahill; Kirk A Frey; Anca M Avram
Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
AJR. American journal of roentgenology 2008;191(6):1785-94.
2008: Jonathan R Dillman; Richard K J Brown; Kirk A Frey; Douglas J Quint
Vertebral body hemangioma visualized on Tc-99m HMPAO-labeled leukocyte SPECT/CT.
Clinical nuclear medicine 2008;33(8):587-90.
2008: Xuehe Li; Yong-Woon Jung; Scott E Snyder; Joseph Blair; Phillip S Sherman; Timothy Desmond; Kirk A Frey; Michael R Kilbourn
5-tert-Butyl-2-(4'-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABA A receptor radioligands.
Nuclear medicine and biology 2008;35(5):549-59.
2008: Roger L Albin; Robert A Koeppe; Nicolaas I Bohnen; Kris Wernette; Michael R Kilbourn; Kirk A Frey
Spared caudal brainstem SERT binding in early Parkinson's disease.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2008;28(3):441-4.
2008: Robert A Koeppe; Sid Gilman; Larry Junck; Kris Wernette; Kirk A Frey
Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2008;4(1 Suppl 1):S67-76.
2007: Fengming P Kong; Kirk A Frey; Leslie E Quint; Randall TenHaken; James A Hayman; Marc Kessler; Indrin Chetty; Daniel Normolle; Avraham Eisbruch; Theodore S Lawrence
A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3116-23.
2007: Oliver G Cameron; Grace C Huang; Thomas Nichols; Robert A Koeppe; Satoshi Minoshima; David Rose; Kirk A Frey
Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder.
Archives of general psychiatry 2007;64(7):793-800.
2007: Nicolaas I Bohnen; Kirk A Frey
Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2007;9(4):243-57.
2007: Rajen J Mody; Chuong Bui; Raymond J Hutchinson; Kirk A Frey; Barry L Shulkin
Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma.
Leukemia & lymphoma 2007;48(4):699-707.
2006: David E Kuhl; Robert A Koeppe; Scott E Snyder; Satoshi Minoshima; Kirk A Frey; Michael R Kilbourn
Imaging butyrylcholinesterase activity in Alzheimer's disease.
Annals of neurology 2006;60(6):746.
2006: Jonathan W Mink; John T Walkup; Kirk A Frey; Peter G Como; Danielle Cath; Mahlon R DeLong; Gerald Erenberg; Joseph Jankovic; Jorge L Juncos; James F Leckman; Neal Swerdlow; Veerle Visser-Vandewalle; Jerrold L Vitek
Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome.
Movement disorders : official journal of the Movement Disorder Society 2006;21(11):1831-8.
2006: Nicolaas I Bohnen; Roger L Albin; Robert A Koeppe; Kris Wernette; Michael R Kilbourn; Satoshi Minoshima; Kirk A Frey
Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2006;26(9):1198-212.
2006: Kirk A Frey; Roger L Albin
Neuroimaging of Tourette syndrome.
Journal of child neurology 2006;21(8):672-7.
2006: Chris-Ellyn Johanson; Kirk A Frey; Leslie Helen Lundahl; Pamela Keenan; Nancy Lockhart; John M Roll; Gantt Galloway; Robert A Koeppe; Michael R Kilbourn; Trevor W Robbins; Charles R Schuster
Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.
Psychopharmacology 2006;185(3):327-38.
2006: Erika A Newman; Vincent M Cimmino; Michael Sabel; Kathleen M Diehl; Kirk A Frey; Alfred E Chang; Lisa A Newman
Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.
Annals of surgical oncology 2006;13(1):52-7.
2006: David E Kuhl; Robert A Koeppe; Scott E Snyder; Satoshi Minoshima; Kirk A Frey; Michael R Kilbourn
In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
Annals of neurology 2006;59(1):13-20.
2005: Sarah M Clinton; Hisham M Ibrahim; Kirk A Frey; Kenneth L Davis; Vahram Haroutunian; James Meador-Woodruff
Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
The American journal of psychiatry 2005;162(10):1859-71.
2005: Kevin A Corcoran; Timothy J Desmond; Kirk A Frey; Stephen Maren
Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(39):8978-87.
2005: Daniel A Hamstra; Bradford Moffat; Daniel E Hall; John M Young; Timothy J Desmond; Julie H Carter; Dennis Pietronigro; Kirk A Frey; Alnawaz Rehemtulla; Brian D Ross
Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study.
Journal of neuro-oncology 2005;73(3):225-38.
2005: Robert A Koeppe; Sid Gilman; Aniket Joshi; Suyu Liu; Roderick Little; Larry Junck; Mary Heumann; Kirk A Frey; Roger L Albin
11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):936-44.
2004: Michael R Kilbourn; Elyse S Kemmerer; Timothy J Desmond; Phillip S Sherman; Kirk A Frey
Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain.
Experimental neurology 2004;188(2):387-90.
2004: giovanni lucignani; Andrea Panzacchi; Laura Bosio; Rosa Maria Moresco; Laura Ravasi; Isabella Coppa; Giuseppe Chiumello; Kirk A Frey; Robert A Koeppe; Ferruccio Fazio
GABA A receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil.
NeuroImage 2004;22(1):22-8.
2004: Satoshi Minoshima; Kirk A Frey; Donna J Cross; David E Kuhl
Neurochemical imaging of dementias.
Seminars in nuclear medicine 2004;34(1):70-82.
2003: Stephen Maren; Carrie R Ferrario; Kevin A Corcoran; Timothy J Desmond; Kirk A Frey
Protein synthesis in the amygdala, but not the auditory thalamus, is required for consolidation of Pavlovian fear conditioning in rats.
The European journal of neuroscience 2003;18(11):3080-8.
2003: Nicolaas I Bohnen; Kirk A Frey
The role of positron emission tomography imaging in movement disorders.
Neuroimaging clinics of North America 2003;13(4):791-803.
2003: David J Brooks; Kirk A Frey; Kenneth Marek; David Oakes; D Paty; R Prentice; Clifford W Shults; A Jon Stoessl
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Experimental neurology 2003;184 Suppl 1():S68-79.
2003: Elyse S Kemmerer; Timothy J Desmond; Roger L Albin; Michael R Kilbourn; Kirk A Frey
Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole.
Experimental neurology 2003;183(1):81-6.
2003: Roger L Albin; Robert A Koeppe; Nicolaas I Bohnen; Thomas E Nichols; P Meyer; Kris Wernette; Satoshi Minoshima; Michael R Kilbourn; Kirk A Frey
Increased ventral striatal monoaminergic innervation in Tourette syndrome.
Neurology 2003;61(3):310-5.
2003: Kevin J Donohoe; Kirk A Frey; Victor H Gerbaudo; Giuliano Mariani; James S Nagel; Barry L Shulkin
Procedure guideline for brain death scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):846-51.
2003: Roger L Albin; Donna Cross; Wayne T Cornblath; John A Wald; Kris Wernette; Kirk A Frey; Satoshi Minoshima
Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia.
Annals of neurology 2003;53(4):528-32.
2003: Roger L Albin; Kirk A Frey
Initial agonist treatment of Parkinson disease: a critique.
Neurology 2003;60(3):390-4.
2002: Roger L Albin; Thomas E Nichols; Kirk A Frey
Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease.
JAMA : the journal of the American Medical Association 2002;288(3):311-2; author reply 312-3.
2002: Masahiko Suzuki; Timothy J Desmond; Roger L Albin; Kirk A Frey
Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias.
Annals of neurology 2002;51(6):767-71.
2002: Kirk A Frey
Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? Against.
European journal of nuclear medicine and molecular imaging 2002;29(5):715-7.
2002: Masahiko Suzuki; Timothy J Desmond; Roger L Albin; Kirk A Frey
Cholinergic vesicular transporters in progressive supranuclear palsy.
Neurology 2002;58(7):1013-8.
2002: Jen-Tzer Gau; Michelle L Steinhilb; Tzu-Cheg Kao; Constance J D'Amato; James R Gaut; Kirk A Frey; Raymond Scott Turner
Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice.
The American journal of pathology 2002;160(2):731-8.
2002: Satoshi Minoshima; Norman L Foster; Eric C Petrie; Roger L Albin; Kirk A Frey; David E Kuhl
Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology.
Journal of geriatric psychiatry and neurology 2002;15(4):200-9.
2001: Anantha Shekhar; Una D McCann; M J Meaney; D C Blanchard; Michael Davis; Kirk A Frey; Israel Liberzon; K L Overall; M K Shear; Laurence H Tecott; L Winsky
Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders.
Psychopharmacology 2001;157(4):327-39.
2001: Masahiko Suzuki; Timothy J Desmond; Roger L Albin; Kirk A Frey
Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
Synapse (New York, N.Y.) 2001;41(4):329-36.
2001: Satoshi Minoshima; Norman L Foster; Anders A F Sima; Kirk A Frey; Roger L Albin; David E Kuhl
Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation.
Annals of neurology 2001;50(3):358-65.
2001: Kirk A Frey; Roger L Albin
Receptor binding techniques.
Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] 2001;Chapter 1():Unit1.4.
2001: Jon K Zubieta; Robert A Koeppe; Kirk A Frey; Michael R Kilbourn; T J Mangner; Norman L Foster; David E Kuhl
Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET.
Synapse (New York, N.Y.) 2001;39(4):275-87.
2001: Kirk A Frey
The neurochemistry of therapeutics: levodopa pharmacodynamics in Parkinson's disease.
Annals of neurology 2001;49(3):285-7.
2001: Jon K Zubieta; Stephan F Taylor; P Huguelet; Robert A Koeppe; Michael R Kilbourn; Kirk A Frey
Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects.
Biological psychiatry 2001;49(2):110-6.
2001: Kirk A Frey; Robert A Koeppe; Michael R Kilbourn
Imaging the vesicular monoamine transporter.
Advances in neurology 2001;86():237-47.
2000: Stephan F Taylor; Robert A Koeppe; Rajiv Tandon; Jon K Zubieta; Kirk A Frey
In vivo measurement of the vesicular monoamine transporter in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;23(6):667-75.
2000: Marc B Skaddan; Michael R Kilbourn; Scott E Snyder; Phillip S Sherman; Timothy J Desmond; Kirk A Frey
Synthesis, (18)F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors.
Journal of medicinal chemistry 2000;43(23):4552-62.
2000: Roger L Albin; Robert A Koeppe; Ronald D Chervin; Flavia B Consens; Kris Wernette; Kirk A Frey; MS Aldrich
Decreased striatal dopaminergic innervation in REM sleep behavior disorder.
Neurology 2000;55(9):1410-2.
2000: Jon K Zubieta; P Huguelet; LE Ohl; Robert A Koeppe; Michael R Kilbourn; J M Carr; Bruno Giordani; Kirk A Frey
High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates.
The American journal of psychiatry 2000;157(10):1619-28.
2000: David E Kuhl; Satoshi Minoshima; Kirk A Frey; Norman L Foster; Michael R Kilbourn; Robert A Koeppe
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex.
Annals of neurology 2000;48(3):391-5.
2000: Kirk A Frey
Neuroimaging in neurotoxicology.
Neurologic clinics 2000;18(3):615-29.
2000: Nicolaas I Bohnen; Robert A Koeppe; P Meyer; Edward P Ficaro; Kris Wernette; Michael R Kilbourn; David E Kuhl; Kirk A Frey; Roger L Albin
Decreased striatal monoaminergic terminals in Huntington disease.
Neurology 2000;54(9):1753-9.
2000: Rita Cowell; Lana Kantor; GH Hewlett; Kirk A Frey; Margaret E Gnegy
Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes.
European journal of pharmacology 2000;389(1):59-65.
2000: Kirk A Frey
Radiotracers and analytical approaches in positron and single-photon emission tomography.
Advances in neurology 2000;83():61-7.
1999: Robert A Koeppe; Kirk A Frey; David E Kuhl; Michael R Kilbourn
Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1999;19(12):1376-84.
1999: Robert A Koeppe; Kirk A Frey; Scott E Snyder; P Meyer; Michael R Kilbourn; David E Kuhl
Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1999;19(10):1150-63.
1999: P Meyer; Nicolaas I Bohnen; Satoshi Minoshima; Robert A Koeppe; Kris Wernette; Michael R Kilbourn; David E Kuhl; Kirk A Frey; Roger L Albin
Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome.
Neurology 1999;53(2):371-4.
1999: Nicolaas I Bohnen; Roger L Albin; Kirk A Frey; John K Fink
(+)-alpha-[11C]Dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis.
Neurology 1999;52(5):1067-9.
1999: David E Kuhl; Robert A Koeppe; Satoshi Minoshima; Scott E Snyder; Edward P Ficaro; Norman L Foster; Kirk A Frey; Michael R Kilbourn
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease.
Neurology 1999;52(4):691-9.
1999: Nicolaas I Bohnen; Satoshi Minoshima; Bruno Giordani; Kirk A Frey; David E Kuhl
Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia.
Neurology 1999;52(3):541-6.
1999: Karley Y Little; Lian Zhang; Timothy J Desmond; Kirk A Frey; Gregory Dalack; Bader J Cassin
Striatal dopaminergic abnormalities in human cocaine users.
The American journal of psychiatry 1999;156(2):238-45.
1999: Page B Pennell; D E Burdette; D A Ross; Thomas R Henry; Roger L Albin; J Chris Sackellares; Kirk A Frey
Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis.
Epilepsia 1999;40(1):38-46.
1998: Jennifer A Kearney; Jill B Becker; Kirk A Frey; Roger L Albin
The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation.
Neuroscience 1998;87(4):881-91.
1998: G K Mulholland; Darryl Wieland; Michael R Kilbourn; Kirk A Frey; Phillip S Sherman; JE Carey; David E Kuhl
[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.
Synapse (New York, N.Y.) 1998;30(3):263-74.
1998: Kirk A Frey; Satoshi Minoshima; David E Kuhl
Neurochemical imaging of Alzheimer's disease and other degenerative dementias.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1998;42(3):166-78.
1998: Jon K Zubieta; Robert A Koeppe; G K Mulholland; David E Kuhl; Kirk A Frey
Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1998;18(6):619-31.
1998: Kieran Murphy; J P Deveikisz; James A Brunberg; David A Jamadar; Kirk A Frey
[O-15]H2O Positron Emission Tomography Determination of Cerebral Blood Flow Reserve after Intravenous Acetazolamide during Balloon Test Occlusion of the Internal Carotid Artery.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 1998;4(1):57-62.
1998: Kieran Murphy; T Payne; David A Jamadar; A Beydoun; Kirk A Frey; James A Brunberg
Correlation of Continuous EEG Monitoring with [O-l5]H2O Positron Emission Tomography Determination of Cerebral Blood Flow during Balloon Test Occlusion of the Internal Carotid Artery. Experience in 34 cases.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 1998;4(1):51-5.
1998: Satoshi Minoshima; Kirk A Frey; David E Kuhl
Cerebellar metabolic reduction in Alzheimer's disease and data normalization.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(2):374-6.
1998: Kirk A Frey; Darryl Wieland; Michael R Kilbourn
Imaging of monoaminergic and cholinergic vesicular transporters in the brain.
Advances in pharmacology (San Diego, Calif.) 1998;42():269-72.
1997: Kirk A Frey; Michael R Kilbourn; T Robinson
Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.
European journal of pharmacology 1997;334(2-3):273-9.
1997: Robert A Koeppe; Kirk A Frey; A Kume; Roger L Albin; Michael R Kilbourn; David E Kuhl
Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1997;17(9):919-31.
1997: Raymond Scott Turner; Ronald D Chervin; Kirk A Frey; Satoshi Minoshima; David E Kuhl
Probable diffuse Lewy body disease presenting as REM sleep behavior disorder.
Neurology 1997;49(2):523-7.
1997: Ben A Dwamena; K K Belcher; Narasimham L Dasika; Kirk A Frey
Focal hyperemia on RBC blood-flow imaging. A scintigraphic marker of arterioportal venous shunting in hepatic cavernous hemangiomas?
Clinical nuclear medicine 1997;22(8):542-5.
1997: GA MacDonald; Kirk A Frey; Bernard W Agranoff; Satoshi Minoshima; Robert A Koeppe; David E Kuhl; Barry L Shulkin; MR Lucey
Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy.
Hepatology (Baltimore, Md.) 1997;26(2):277-82.
1997: Satoshi Minoshima; Bruno Giordani; Stanley Berent; Kirk A Frey; Norman L Foster; David E Kuhl
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
Annals of neurology 1997;42(1):85-94.
1997: Jennifer A Kearney; Kirk A Frey; Roger L Albin
Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(11):4415-25.
1997: T Vander Borght; Satoshi Minoshima; Bruno Giordani; Norman L Foster; Kirk A Frey; Stanley Berent; Roger L Albin; Robert A Koeppe; David E Kuhl
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(5):797-802.
1997: Charles R Meyer; JL Boes; Boklye Kim; Peyton H Bland; Kenneth R Zasadny; Paul Kison; Kenneth F Koral; Kirk A Frey; Richard L Wahl
Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations.
Medical image analysis 1997;1(3):195-206.
1997: Michael R Kilbourn; A Charalambous; Kirk A Frey; Phillip Sherman; Donald S Higgins; J Timothy Greenamyre
Intrastriatal neurotoxin injections reduce in vitro and in vivo binding of radiolabeled rotenoids to mitochondrial complex I.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1997;17(3):265-72.
1997: Boklye Kim; JL Boes; Kirk A Frey; Charles R Meyer
Mutual information for automated unwarping of rat brain autoradiographs.
NeuroImage 1997;5(1):31-40.
1996: Sid Gilman; Kirk A Frey; Robert A Koeppe; Larry Junck; R Little; T M Vander Borght; M Lohman; S Martorello; L C Lee; Douglas M Jewett; Michael R Kilbourn
Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography.
Annals of neurology 1996;40(6):885-92.
1996: Kirk A Frey; Robert A Koeppe; Michael R Kilbourn; T M Vander Borght; Roger L Albin; Sid Gilman; David E Kuhl
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
Annals of neurology 1996;40(6):873-84.
1996: Robert A Koeppe; Kirk A Frey; T M Vander Borght; A Karlamangla; Douglas M Jewett; L C Lee; Michael R Kilbourn; David E Kuhl
Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1996;16(6):1288-99.
1996: A Buck; G K Mulholland; S M Papadopoulos; Robert A Koeppe; Kirk A Frey
Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1996;16(6):1280-7.
1996: David E Kuhl; Satoshi Minoshima; Jeffrey A Fessler; Kirk A Frey; Norman L Foster; Edward P Ficaro; Darryl Wieland; Robert A Koeppe
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.
Annals of neurology 1996;40(3):399-410.
1996: Yong-Woon Jung; Kirk A Frey; G K Mulholland; R del Rosario; Phillip S Sherman; David M Raffel; Marcian E Van Dort; David E Kuhl; D L Gildersleeve; Darryl Wieland
Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol.
Journal of medicinal chemistry 1996;39(17):3331-42.
1996: Roger L Albin; Satoshi Minoshima; Constance J D'Amato; Kirk A Frey; D A Kuhl; Anders A F Sima
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.
Neurology 1996;47(2):462-6.
1996: Michael R Kilbourn; Kirk A Frey
Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.
European journal of pharmacology 1996;307(2):227-32.
1996: R S Brown; J Y Leung; S J Fisher; Kirk A Frey; Stephen Ethier; Richard L Wahl
Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(6):1042-7.
1996: Michael R Kilbourn; Kirk A Frey; T Vander Borght; Phillip S Sherman
Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters.
Nuclear medicine and biology 1996;23(4):467-71.
1996: Kirk A Frey; Satoshi Minoshima; Robert A Koeppe; Michael R Kilbourn; K L Berger; David E Kuhl
Stereotaxic summation analysis of human cerebral benzodiazepine binding maps.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1996;16(3):409-17.
1996: Kung-Shing Lee; Kirk A Frey; Robert A Koeppe; A Buck; G K Mulholland; David E Kuhl
In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1996;16(2):303-10.
1996: L C Lee; T Vander Borght; Phillip S Sherman; Kirk A Frey; Michael R Kilbourn
In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
Journal of medicinal chemistry 1996;39(1):191-6.
1995: T Vander Borght; Michael R Kilbourn; T Desmond; David E Kuhl; Kirk A Frey
The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.
European journal of pharmacology 1995;294(2-3):577-83.
1995: T M Vander Borght; Michael R Kilbourn; Robert A Koeppe; J N DaSilva; JE Carey; David E Kuhl; Kirk A Frey
In vivo imaging of the brain vesicular monoamine transporter.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(12):2252-60.
1995: G N Groom; Larry Junck; Norman L Foster; Kirk A Frey; David E Kuhl
PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(12):2207-10.
1995: T M Vander Borght; Anders A F Sima; Michael R Kilbourn; T J Desmond; David E Kuhl; Kirk A Frey
[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity.
Neuroscience 1995;68(3):955-62.
1995: R S Brown; J Y Leung; S J Fisher; Kirk A Frey; Stephen Ethier; Richard L Wahl
Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(10):1854-61.
1995: Satoshi Minoshima; Kirk A Frey; Robert A Koeppe; Norman L Foster; David E Kuhl
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1238-48.
1995: Satoshi Minoshima; Kirk A Frey; Norman L Foster; David E Kuhl
Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis.
Journal of computer assisted tomography 1995;19(4):541-7.
1995: Michael R Kilbourn; L Lee; T Vander Borght; Douglas M Jewett; Kirk A Frey
Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
European journal of pharmacology 1995;278(3):249-52.
1995: D E Burdette; S Y Sakurai; Thomas R Henry; D A Ross; Page B Pennell; Kirk A Frey; J Chris Sackellares; Roger L Albin
Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy.
Neurology 1995;45(5):934-41.
1995: A Charalambous; L Tluczek; Kirk A Frey; D S Higgins; T J Greenamyre; Michael R Kilbourn
Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6',7'-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity.
Nuclear medicine and biology 1995;22(4):491-6.
1995: M Meyer; Robert A Koeppe; Kirk A Frey; Norman L Foster; David E Kuhl
Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.
Archives of neurology 1995;52(3):314-7.
1995: G K Mulholland; Michael R Kilbourn; P Sherman; JE Carey; Kirk A Frey; Robert A Koeppe; David E Kuhl
Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist.
Nuclear medicine and biology 1995;22(1):13-7.
1994: Allan Levey; S M Edmunds; Craig J Heilman; T J Desmond; Kirk A Frey
Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain.
Neuroscience 1994;63(1):207-21.
1994: Satoshi Minoshima; Robert A Koeppe; Kirk A Frey; David E Kuhl
Anatomic standardization: linear scaling and nonlinear warping of functional brain images.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(9):1528-37.
1994: Satoshi Minoshima; Robert A Koeppe; Kirk A Frey; M Ishihara; David E Kuhl
Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(6):949-54.
1994: R B Kuppersmith; Michael J Disher; John P Deveikis; Kirk A Frey; B L Shulkin; R A Clevens; Gregory T Wolf
Management of an osteogenic sarcoma of the maxilla.
The Annals of otology, rhinology, and laryngology 1994;103(5 Pt 1):408-12.
1994: Roger L Albin; M M Howland; D S Higgins; Kirk A Frey
Autoradiographic quantification of muscarinic cholinergic synaptic markers in bat, shrew, and rat brain.
Neurochemical research 1994;19(5):581-9.
1994: James A Brunberg; Kirk A Frey; J A Horton; John P Deveikis; D A Ross; Robert A Koeppe
[15O]H2O positron emission tomography determination of cerebral blood flow during balloon test occlusion of the internal carotid artery.
AJNR. American journal of neuroradiology 1994;15(4):725-32.
1994: David E Kuhl; Robert A Koeppe; Jeffrey A Fessler; Satoshi Minoshima; R J Ackermann; JE Carey; D L Gildersleeve; Kirk A Frey; Darryl Wieland
In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(3):405-10.
1994: Kenneth L Casey; Satoshi Minoshima; K L Berger; Robert A Koeppe; Thomas J Morrow; Kirk A Frey
Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli.
Journal of neurophysiology 1994;71(2):802-7.
1994: Robert A Koeppe; Kirk A Frey; G K Mulholland; Michael R Kilbourn; A Buck; Kung-Shing Lee; David E Kuhl
[11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1994;14(1):85-99.
1993: Daniel L Murman; Kirk A Frey
Neuroimaging of epilepsy, movement disorders, and degenerative diseases.
Current opinion in neurology 1993;6(6):919-26.
1993: D R Schwartz; Jochen Schacht; Josef M Miller; Kirk A Frey; Richard A Altschuler
Chronic electrical stimulation reverses deafness-related depression of electrically evoked 2-deoxyglucose activity in the guinea pig inferior colliculus.
Hearing research 1993;70(2):243-9.
1993: Thomas R Henry; Kirk A Frey; J Chris Sackellares; Sid Gilman; Robert A Koeppe; James A Brunberg; D A Ross; Stanley Berent; Anne B Young; David E Kuhl
In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy.
Neurology 1993;43(10):1998-2006.
1993: M A Meyer; Kirk A Frey; M Schwaiger
Discordance between F-18 fluorodeoxyglucose uptake and contrast enhancement in a brain abscess.
Clinical nuclear medicine 1993;18(8):682-4.
1993: V A Holthoff; Robert A Koeppe; Kirk A Frey; John B Penney; Dorene S Markel; David E Kuhl; Anne B Young
Positron emission tomography measures of benzodiazepine receptors in Huntington's disease.
Annals of neurology 1993;34(1):76-81.
1993: Michael R Kilbourn; J N DaSilva; Kirk A Frey; Robert A Koeppe; David E Kuhl
In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography.
Journal of neurochemistry 1993;60(6):2315-8.
1993: Satoshi Minoshima; Robert A Koeppe; M A Mintun; K L Berger; Stephan F Taylor; Kirk A Frey; David E Kuhl
Automated detection of the intercommissural line for stereotactic localization of functional brain images.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(2):322-9.
1993: Jon K Zubieta; Kirk A Frey
Autoradiographic mapping of M3 muscarinic receptors in the rat brain.
The Journal of pharmacology and experimental therapeutics 1993;264(1):415-22.
1992: Kirk A Frey; M M Howland
Quantitative autoradiography of muscarinic cholinergic receptor binding in the rat brain: distinction of receptor subtypes in antagonist competition assays.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1391-400.
1992: Stephan F Taylor; Kirk A Frey; Ronald M Baldwin; S M Papadopoulos; Neil Petry; W L Rogers; B J McBride; J M Kerr; David E Kuhl
Technetium-99m-N1-(2-mercapto-2-methylpropyl)-N2-(2-propargylthio-2- methylpropyl)-1,2-benzenediamine (T691): preclinical studies of a potential new tracer of regional cerebral perfusion.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(10):1836-42.
1992: Kirk A Frey; Robert A Koeppe; G K Mulholland; Douglas M Jewett; R Hichwa; R L Ehrenkaufer; JE Carey; Darryl Wieland; David E Kuhl; Bernard W Agranoff
In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1992;12(1):147-54.
1992: James A Brunberg; Kirk A Frey; J A Horton; David E Kuhl
Crossed cerebellar diaschisis: occurrence and resolution demonstrated with PET during carotid temporary balloon occlusion.
AJNR. American journal of neuroradiology 1992;13(1):58-61.
1991: Kirk A Frey; V A Holthoff; Robert A Koeppe; Douglas M Jewett; Michael R Kilbourn; David E Kuhl
Parametric in vivo imaging of benzodiazepine receptor distribution in human brain.
Annals of neurology 1991;30(5):663-72.
1991: V A Holthoff; Robert A Koeppe; Kirk A Frey; A H Paradise; David E Kuhl
Differentiation of radioligand delivery and binding in the brain: validation of a two-compartment model for [11C]flumazenil.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1991;11(5):745-52.
1991: Kirk A Frey; B Ciliax; Bernard W Agranoff
Quantitative in vivo receptor binding. IV: Detection of muscarinic receptor down-regulation by equilibrium and by tracer kinetic methods.
Neurochemical research 1991;16(9):1017-23.
1991: Robert A Koeppe; V A Holthoff; Kirk A Frey; Michael R Kilbourn; David E Kuhl
Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1991;11(5):735-44.
1991: James C Sisson; Darryl Wieland; Robert A Koeppe; Daniel Normolle; Kirk A Frey; Gerald R Bolgos; J Johnson; Marcian E Van Dort; D L Gildersleeve
Scintigraphic portrayal of beta receptors in the heart.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(7):1399-407.
1990: D A Evans; John K Niparko; Richard A Altschuler; Kirk A Frey; Josef M Miller
Demonstration of prosthetic activation of central auditory pathways using [14C]-2-deoxyglucose.
The Laryngoscope 1990;100(2 Pt 1):128-37.
1988: I Shimoyama; G W Dauth; Sid Gilman; Kirk A Frey; John B Penney
Thalamic, brainstem, and cerebellar glucose metabolism in the hemiplegic monkey.
Annals of neurology 1988;24(6):718-26.
1988: Bernard W Agranoff; Stephen K Fisher; Anne M Heacock; Kirk A Frey
The phosphoinositide-linked CNS muscarinic receptor.
Advances in experimental medicine and biology 1988;236():195-215.
1987: Sid Gilman; G W Dauth; Kirk A Frey; John B Penney
Experimental hemiplegia in the monkey: basal ganglia glucose activity during recovery.
Annals of neurology 1987;22(3):370-6.
1986: Kirk A Frey; B W Agranoff; Anne B Young; R D Hichwa; R L Ehrenkaufer
Human brain receptor distribution.
Science (New York, N.Y.) 1986;232(4755):1269-71.
1985: J L Olds; Kirk A Frey; R L Ehrenkaufer; B W Agranoff
A sequential double-label autoradiographic method that quantifies altered rates of regional glucose metabolism.
Brain research 1985;361(1-2):217-24.
1985: Kirk A Frey; R D Hichwa; R L Ehrenkaufer; Bernard W Agranoff
Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(19):6711-5.
1985: Kirk A Frey; R L Ehrenkaufer; B W Agranoff
Quantitative in vivo receptor binding. II. Autoradiographic imaging of muscarinic cholinergic receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1985;5(9):2407-14.
1985: G W Dauth; Sid Gilman; Kirk A Frey; John B Penney
Basal ganglia glucose utilization after recent precentral ablation in the monkey.
Annals of neurology 1985;17(5):431-8.
1985: Kirk A Frey; R L Ehrenkaufer; S Beaucage; B W Agranoff
Quantitative in vivo receptor binding. I. Theory and application to the muscarinic cholinergic receptor.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1985;5(2):421-8.
1984: B W Agranoff; Kirk A Frey
A regional metabolic contrast method for the study of brain pathology.
Annals of neurology 1984;15 Suppl():S93-7.
1984: Sid Gilman; G W Dauth; Kirk A Frey; J Wayne Aldridge; John B Penney
Basal ganglia glucose metabolic and single neural unit activity in experimental hemiplegia.
International journal of neurology 1984;18():79-93.
1983: G W Dauth; Kirk A Frey; Sid Gilman
A densitometer for quantitative autoradiography.
Journal of neuroscience methods 1983;9(3):243-51.
1983: H S Pan; Kirk A Frey; Anne B Young; John B Penney
Changes in [3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1983;3(6):1189-98.
1983: Kirk A Frey; B W Agranoff
Barbiturate-enhanced detection of brain lesions by carbon-14-labeled 2-deoxyglucose autoradiography.
Science (New York, N.Y.) 1983;219(4586):879-81.
1981: Stephen K Fisher; Kirk A Frey; B W Agranoff
Loss of muscarinic receptors and of stimulated phospholipid labeling in ibotenate-treated hippocampus.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1981;1(12):1407-13.
1981: John B Penney; H S Pan; Anne B Young; Kirk A Frey; G W Dauth
Quantitative autoradiography of [3H]muscimol binding in rat brain.
Science (New York, N.Y.) 1981;214(4524):1036-8.
1981: Kirk A Frey; D M Wieland; L E Brown; W L Rogers; B W Agranoff
Development of a tomographic myelin scan.
Annals of neurology 1981;10(3):214-21.
1981: J B Penney; Kirk A Frey; Anne B Young
Quantitative autoradiography of neurotransmitter receptors using tritium-sensitive film.
European journal of pharmacology 1981;72(4):421-2.